101 results
6-K
ASND
Ascendis Pharma A/S
2 May 24
Current report (foreign)
4:29pm
with its subsidiaries, is applying its innovative TransCon technology platform to build a leading, fully integrated, global biopharma company focused … forward-looking statements by these cautionary statements.
Overview
We are applying our innovative TransCon technology platform to build a leading
6-K
EX-99.1
ASND
Ascendis Pharma A/S
2 May 24
Ascendis Pharma Reports First Quarter 2024 Financial Results
4:22pm
Pharma website shortly after conclusion of the event for 30 days.
About Ascendis Pharma A/S
Ascendis Pharma is applying its innovative TransCon
6-K
EX-99.2
ASND
Ascendis Pharma A/S
2 May 24
Notice to convene Annual General Meeting 2024
4:02pm
) for the Year x 100) / Average Equity
Equity Ratio: (Equity x 100) / Total Assets
Ascendis Pharma in Brief
We are applying our innovative TransCon … , pursuing clinical conditions, innovative life cycle management, and complementary patient offerings
Expand pipeline with Endocrinology Rare Disease
6-K
EX-99.3
ASND
Ascendis Pharma A/S
2 May 24
Notice to convene Annual General Meeting 2024
4:02pm
innovative approaches such as decentralization of clinical trials, which includes elements like eConsent, home nurse services, shipping of study drug … -being. Access to Medicine At Ascendis Pharma, we are dedicated to accelerating the availability of our innovative medicines to patients. To this end
6-K
EX-99.1
u3g4u3hc8dglksj
7 Feb 24
Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results
4:05pm
6-K
EX-99.1
pqk cc86j88k5w
8 Jan 24
Current report (foreign)
6:08am
6-K
nuhfa3h8f42kbfro7
8 Jan 24
Current report (foreign)
6:05am
6-K
9sg388r8
7 Nov 23
Current report (foreign)
4:03pm
6-K
EX-99.1
j0je9h q3
7 Nov 23
Ascendis Pharma Reports Third Quarter 2023 Financial Results
4:01pm
6-K
0ussi8tayq
5 Sep 23
Current report (foreign)
4:14pm
6-K
EX-99.1
qkun4
5 Sep 23
Ascendis Pharma Reports Second Quarter 2023 Financial Results
4:09pm
6-K
EX-99.1
6ybpah87 hdh
31 May 23
Current report (foreign)
12:01pm
6-K
EX-99.2
ntkzgm
2 May 23
Notice to convene Annual General Meeting 2023
4:02pm
6-K
EX-99.3
mn5tzi99sba au00tf6r
2 May 23
Notice to convene Annual General Meeting 2023
4:02pm
6-K
7ji5x
27 Apr 23
Current report (foreign)
4:02pm
6-K
EX-99.1
jn42by8 g9
27 Apr 23
Ascendis Pharma Reports First Quarter 2023 Financial Results
4:01pm
6-K
8bcyegk0bu2bkr3u
2 Nov 22
Current report (foreign)
4:31pm
6-K
EX-99.1
kyye fvreclrf
2 Nov 22
Ascendis Pharma Reports Third Quarter 2022 Financial Results
4:05pm
6-K
co6507 ie06hjqgksdoz
10 Aug 22
Current report (foreign)
4:13pm